Specifically, we discovered that fucosylation of tumor-expressed MHC-II protein HLA-DRB1 triggers CD4+T cell-mediated induction of tumor-infiltrating immune cells and tumor suppression (68). The gene discussed is CD4; the disease is neoplasm.